On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

INCLIVA Health Research Institute

InstitutionResearch output, impact & collaborations

INCLIVA Health Research Institute is a institution indexed in ScholarIQ from OpenAlex.

What is known about INCLIVA Health Research Institute?

ScholarIQrecord summary

INCLIVA Health Research Institute is a research organisation in Valencia, ES. OpenAlex records 5,882 works and 519,610 citations for it. 1,717 researchers list it as their most recent affiliation.

How many works does INCLIVA Health Research Institute have?

ScholarIQindexed works

INCLIVA Health Research Institute has 5,882 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does INCLIVA Health Research Institute have?

ScholarIQcitation count

INCLIVA Health Research Institute has 519,610 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at INCLIVA Health Research Institute?

ScholarIQresearcher count

INCLIVA Health Research Institute has 1,717 researchers in the ScholarIQ index.

What is the average h-index at INCLIVA Health Research Institute?

ScholarIQavg h-index

INCLIVA Health Research Institute has an average h-index of 98 in OpenAlex.

What is the ROR of INCLIVA Health Research Institute?

ScholarIQror

The ROR for INCLIVA Health Research Institute is on the source record.

What is the OpenAlex record for INCLIVA Health Research Institute?

ScholarIQopenalex

The OpenAlex for INCLIVA Health Research Institute is on the source record.

Who are the most-cited researchers behind INCLIVA Health Research Institute?

ScholarIQtop researchers by citations
1
Andrés Cervantes · Colorectal Cancer Treatments and Studies
1,118 works62,201 citations

What are the most-cited papers on INCLIVA Health Research Institute?

ScholarIQmost cited works
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Timothy Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder, Andreas du Bois, Jalid Sehouli, Rainer Kimmig, Anne Stähle, Fiona Collinson, Sharadah Essapen, Charlie Gourley, Alain Lortholary, Frédèric Selle, Mansoor R. Mirza, Arto Leminen, Marie Plante, Dan Stark, Wendi Qian, Mahesh Parmar, Amit M. Oza
New England Journal of Medicine. 20112,162 CitationsOPEN ACCESS
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, Corrie A.M. Marijnen, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Annet G.H. Roodvoets, Irıs D. Nagtegaal, Regina G. H. Beets‐Tan, Lennart K. Blomqvist, Tone Fokstuen, Albert J. ten Tije, Jaume Capdevila, Mathijs P. Hendriks, Ibrahim Edhemović, Andrés Cervantes, Per J. Nilsson, Bengt Glimelius, Cornelis J.�H. van de Velde, Geke A.P. Hospers, Lars Østergaard, Frank Svendsen Jensen, Per Pfeiffer, K.E.J. Jensen, Mathijs P. Hendriks, Wilhelmina H. Schreurs, H.P. Knol, J.J. van der Vliet, Jurriaan B. Tuynman, A. Bruynzeel, Emile D. Kerver, Sebastiaan Festen, Monique E. van Leerdam, Geerard L. Beets, L. Dewit, C.J.A. Punt, Pieter J. Tanis, Elisabeth D. Geijsen, Peter Nieboer, Wim Bleeker, Albert J. ten Tije, Rogier M. P. H. Crolla, Addy C.M. van de Luijtgaarden, Jan Willem T. Dekker, J.M. Immink, Frank J. Jeurissen, Andreas Marinelli, Heleen M. Ceha, Tanja C. Stam, P. Quarles an Ufford, Willem H. Steup, Alex L.T. Imholz, R.J.I. Bosker, Jasper Bekker, G.J. Creemers, Grard A. P. Nieuwenhuijzen, Henk van den Berg, Wendy M. van der Deure, Roderick F. Schmitz, Johan M. van Rooijen, Annette F. T. Olieman, A.C.M. van den Bergh, Derk Jan A. de Groot, Klaas Havenga, Jannet C. Beukema, Jacob D. de Boer, Peter H.J.M. Veldman, Ester Siemerink, J.W.P. Vanstiphout, B. De Valk, Q. A. J. Eijsbouts, M. Polée, Christiaan Hoff, Annerie Slot, H.W. Kapiteijn, Koen Peeters, Femke P. Peters, P.A. Nijenhuis, Sandra A. Radema, Hans De Wilt, Pètra M. Braam, G.J. Veldhuis, Daniël A. Hess, Tom Rozema, O. Reerink, Daan ten Bokkel Huinink, A. Pronk, Josephine M. I. Vos, Metin Tascilar, Gijs A. Patijn, Christian Kersten, Odd Mjåland, Marianne G. Guren, Arild Nesbakken, Janez Benedik, Ibrahim Edhemović, Vaneja Velenik, Jaume Capdevila, Eloy Espín, Ramón Salazar
The Lancet Oncology. 20201,669 CitationsOPEN ACCESS
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung‐Won Park‐Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh Parmar, Timothy Perren
The Lancet Oncology. 2015868 CitationsOPEN ACCESS
Integration of oncology and palliative care: a Lancet Oncology Commission
Stein Kaasa, Jon Håvard Loge, Matti Aapro, Tit Albreht, Rebecca Anderson, Éduardo Bruera, Cinzia Brunelli, Augusto Caraceni, Andrés Cervantes, David C. Currow, Luc Deliëns, Marie Fallon, Xavier Gómez‐Batiste, Kjersti Støen Grotmol, Breffni Hannon, Dagny Faksvåg Haugen, Irene J Higginson, Marianne Jensen Hjermstad, David Hui, Karin Jordan, Geana Paula Kurita, Philip Larkin, Guido Miccinesi, Friedemann Nauck, Rade Pribakovic, Gary Rodin, Per Sjøgren, Patrick Stone, Camilla Zimmermann, Tonje Lundeby
The Lancet Oncology. 2018847 CitationsOPEN ACCESS
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, George Pentheroudakis, Kentaro Yamazaki, Rui‐Hua Xu, Tae‐Woo Kim, Muhammad Ismail, Iain Tan, Kun‐Huei Yeh, Axel Grothey, S. Zhang, Joong Bae Ahn, M.Y. Mastura, Dawn Q. Chong, Liqun Chen, Scott Kopetz, Takako Eguchi-Nakajima, Hiromichi Ebi, Atsushi Ohtsu, Andrés Cervantes, Kei Muro, Josep Tabernero, Hironobu Minami, Fortunato Ciardiello, Jean‐Yves Douillard
Annals of Oncology. 2017596 CitationsOPEN ACCESS

How much of the research on INCLIVA Health Research Institute is open access?

ScholarIQopen access share
83%OPEN ACCESS
Gold
0%
Green
17%
Hybrid
33%
Bronze
33%
Closed
17%

Related on ScholarIQ

470M+ articles · 14-day free trial